Head-to-Head

ABBVIE INC. vs. Aktis Oncology, Inc. Common stock

ABBV

ABBVIE INC.

$295.03 +0.20%

VS AKTS

Aktis Oncology, Inc. Common stock

$16.55 -0.45%

ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABBVAKTS
Market Cap $521.50 billion $927.36 million

ABBV leads on 1 of 1 size & scale factors.

Dividend

ABBVAKTS
Dividend Yield 2.47% —

ABBV and AKTS split the dividend factors evenly.

Risk & Sentiment

ABBVAKTS
Short Interest 0.85% 1.61%

ABBV leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, AKTS overview, AKTS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.